Search

Your search keyword '"Heendeniya, Amila"' showing total 15 results
Start Over Author "Heendeniya, Amila"
15 results on '"Heendeniya, Amila"'

1. Body Louse Pathogen Surveillance among Persons Experiencing Homelessness, Canada, 2020-2021

Author

Boodman, Carl, Lindsay, Leslie R., Dibernardo, Antonia, Kisil, Kathy, Coatsworth, Heather, Huynh, Chris, Heendeniya, Amila, Schellenberg, John, and Keynan, Yoav

Subjects
Verruga peruana -- Causes of -- Demographic aspects, Homeless persons -- Health aspects, Bartonella -- Health aspects -- Distribution, Health, Company distribution practices, Distribution, Demographic aspects, Health aspects, Causes of
Abstract

In 2020, Canada's largest cluster of Bartonella quintana endocarditis, an infection caused by a louseborne bacterium, was detected among persons experiencing homelessness in Winnipeg, Manitoba, Canada (1). Over a 6-month [...]

Published
2024
Full Text
View/download PDF

10. HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.

Author

Tumarkin, Ethan, Heendeniya, Amila, Murphy, Pauline, Placido, Tania, Tan, Darrell H. S., and Bogoch, Isaac I.

Abstract

Background: On-demand preexposure prophylaxis may reduce one's risk of HIV acquisition; however, it is unclear if individuals with a very low frequency of HIV exposures are conferred adequate protection. We evaluated a novel approach dubbed HIV post-exposure prophylaxis-in-pocket ("PIP"), for individuals with a low frequency of high-risk HIV exposures. Setting: Two HIV clinics in Toronto, Canada, managing HIV prevention cases. Methods: A retrospective evaluation of patients referred to HIV clinics for preexposure prophylaxis between January 1, 2013, and September 30, 2017, inclusive. After counseling and education, selected patients were initiated on PIP if they were having very infrequent HIV exposures. Results: Thirty patients were prescribed PIP. Four patients (13.3%) used PIP during this study. There were no HIV seroconversions in 21.8 cumulative patient-years of PIP. Conclusions: PIP may be a useful HIV prevention modality for individuals with a very low frequency of HIV exposures. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

13. HIV preexposure prophylaxis in Canadian primary care and community settings.

Author

Heendeniya A, Tumarkin E, and Bogoch II

Subjects
Canada, HIV Infections drug therapy, Humans, Primary Health Care methods, Risk Factors, Anti-HIV Agents therapeutic use, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination therapeutic use, HIV Infections prevention & control, Pre-Exposure Prophylaxis methods
Published
2019

14. Progressive multifocal leukoencephalopathy unmasked by antiretroviral therapy for HIV.

Author

Coomes EA, Heendeniya A, and Bunce PE

Subjects
Disease Progression, Glucocorticoids therapeutic use, Humans, Leukoencephalopathy, Progressive Multifocal drug therapy, Magnetic Resonance Imaging, Male, Methylprednisolone therapeutic use, Middle Aged, Prednisone therapeutic use, Virus Activation, Anti-Retroviral Agents therapeutic use, HIV Infections drug therapy, Immune Reconstitution Inflammatory Syndrome diagnosis, Leukoencephalopathy, Progressive Multifocal diagnostic imaging
Abstract

Competing Interests: Competing interests: None declared.

Published
2018
Full Text
View/download PDF

15. Brief Report: HIV Postexposure Prophylaxis-in-Pocket ("PIP") for Individuals With Low-Frequency, High-Risk HIV Exposures.

Author

Tumarkin E, Heendeniya A, Murphy P, Placido T, Tan DHS, and Bogoch II

Subjects
Adult, Anti-HIV Agents therapeutic use, Canada, Counseling, Female, HIV pathogenicity, Humans, Male, Middle Aged, Pre-Exposure Prophylaxis methods, Program Evaluation, Retrospective Studies, Sexual Health, HIV Infections prevention & control, HIV Infections transmission, Post-Exposure Prophylaxis methods
Abstract

Background: On-demand preexposure prophylaxis may reduce one's risk of HIV acquisition; however, it is unclear if individuals with a very low frequency of HIV exposures are conferred adequate protection. We evaluated a novel approach dubbed HIV postexposure prophylaxis-in-pocket ("PIP"), for individuals with a low frequency of high-risk HIV exposures., Setting: Two HIV clinics in Toronto, Canada, managing HIV prevention cases., Methods: A retrospective evaluation of patients referred to HIV clinics for preexposure prophylaxis between January 1, 2013, and September 30, 2017, inclusive. After counseling and education, selected patients were initiated on PIP if they were having very infrequent HIV exposures., Results: Thirty patients were prescribed PIP. Four patients (13.3%) used PIP during this study. There were no HIV seroconversions in 21.8 cumulative patient-years of PIP., Conclusions: PIP may be a useful HIV prevention modality for individuals with a very low frequency of HIV exposures.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results